National Catholic Register News
https://www.ncregister.com/tag/abortion-pills
A first-of-its-kind study by the Ethics and Public Policy Center that delves into public-health insurance records found that more than 1 in 10 women who take mifepristone to complete a chemical abortion will suffer a serious health complication during the process.
This is the first post-Roe case in which a court official in one state refused to cooperate with a judicial ruling from another state on a matter related to interstate abortion services.
The fight over abortion pills intensifies as Democrats attempt to safeguard access while Republicans consider regulatory rollbacks.
Kennedy said President Donald Trump has directed him to investigate the drug.
Chemical abortions currently account for about half of the abortions that are done in the United States every year.
More than 15 states have laws prohibiting abortions earlier than the 12th week of pregnancy.
The suit against Sage Publications, filed on Oct. 3 in the Superior Court for Ventura County, California, alleges that the researchers’ studies were retracted simply because of the scientists’ pro-life views.
The report by the American Life League criticizes government officials for doing little to stop a pro-abortion ‘cartel’ from shipping pills to states that ban or regulate access to abortion.
COMMENTARY: An educated public remains the best defense against the FDA’s reckless actions.
Passed in 1873, the Comstock Act bans in part the usage of the U.S. Postal Service to send any materials that can facilitate or cause abortions.
Subscriber Service CenterAlready a subscriber? Renew or manage your subscription or gift subscription.
My AccountSubscribe for just $49.95 $32.50!Start your Register subscription today.
Give a Gift SubscriptionBless friends, family or clergy with a gift of the Register.
Order NowOrder Bulk SubscriptionsGet a discount on 6 or more copies sent to your parish, organization or school.
Order NowSign-up for E-NewsletterGet Register Updates sent daily or weeklyto your inbox.
Sign Up
